Strains Preferentially Disseminate to the Central Nervous System during Coinfection
Departments of Molecular Genetics and Microbiology,1 Cell Biology,2 Medicine,3 Pediatrics,4 Pharmacology and Cancer Biology,5 Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710,6 Divisions of Infectious Diseases,7 Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461,8 Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 021149
Received 14 February 2005/ Returned for modification 7 March 2005/ Accepted 15 March 2005
Cryptococcus neoformans is a fungal pathogen that has evolved over the past 40 million years into three distinct varieties or sibling species (gattii, grubii, and neoformans). Each variety manifests differences in epidemiology and disease, and var. grubii strains are responsible for the vast majority of human disease. In previous studies,
strains were more virulent than congenic a strains in var. neoformans, whereas var. grubii congenic a and
strains exhibited equivalent levels of virulence. Here the role of mating type in the virulence of var. grubii was further characterized in a panel of model systems. Congenic var. grubii a and
strains had equivalent survival rates when cultured with amoebae, nematodes, and macrophages. No difference in virulence was observed between a and
congenic strains in multiple inbred-mouse genetic backgrounds, and there was no difference in accumulations in the central nervous system (CNS) late in infection. In contrast, during coinfections, a and
strains are equivalent in peripheral tissues but
cells have an enhanced predilection to penetrate the CNS. These studies reveal the first virulence difference between congenic a and
strains in the most common pathogenic variety and suggest an explanation for the prevalence of
strains in clinical isolates.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|